Silk Road Medical names Chas McKhann CEO effective Nov 2, 2023; Erica Rogers retires

Silk Road Medical Inc

Chas McKhann appointed CEO and director effective November 2, 2023, succeeding Erica Rogers who retired.
McKhann receives $650K base salary, $100K sign-on bonus, target bonus of 100% of salary.
McKhann granted 612,083 RSUs (4-year vesting) and 612,083 PSUs (relative TSR performance vesting).
Rogers enters consulting agreement for one year at $55K/month; her PSUs forfeited, RSUs accelerate, option extension.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Charles (Chas) McKhann

Chief Executive Officer

Silk Road Medical Inc

Effective: 2023-11-02
Filed: November 2, 2023, 7:59 PM ET

On November 2, 2023, Silk Road Medical, Inc. (the “Company”) announced the appointment of Charles (Chas) McKhann as Chief Executive Officer (“CEO”) and a director of the Company, effective immediately.

Departed

Erica J. Rogers

President and Chief Executive Officer

Silk Road Medical Inc

Effective: 2023-11-02
Successor: Charles (Chas) McKhann
Filed: November 2, 2023, 7:59 PM ET

Mr. McKhann will succeed Erica J. Rogers, who is retiring, effective November 2, 2023, and has served on the Company’s Board of Directors and as President and Chief Executive Officer for over 11 years.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Charles (Chas) McKhann was appointed as Chief Executive Officer at Silk Road Medical Inc.

Action: appointed
Role: Chief Executive Officer

Exact text from the filing

On November 2, 2023, Silk Road Medical, Inc. (the “Company”) announced the appointment of Charles (Chas) McKhann as Chief Executive Officer (“CEO”) and a director of the Company, effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Erica J. Rogers retired as President and Chief Executive Officer at Silk Road Medical Inc.

Action: retired
Role: President and Chief Executive Officer

Exact text from the filing

Mr. McKhann will succeed Erica J. Rogers, who is retiring, effective November 2, 2023, and has served on the Company’s Board of Directors and as President and Chief Executive Officer for over 11 years.

View on SEC.gov

Source: SEC EDGAR

accession 0001397702-23-000061

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.